Earnings$BSX6:30 AM ETdeveloping · v11

Boston Scientific Q3 net sales $5.14B, adjusted EPS $0.73; guides FY 2026 sales growth ~4.25%

By BORSA NewsroomPublished Oct 28, 2026, 6:30 AM EDTUpdated Oct 28, 2026, 6:31 AM EDT

Boston Scientific reported Q3 net sales of $5.138B, up 1.5%, and adjusted EPS of $0.73, down from $0.75 a year ago. The company guided full-year 2026 organic sales growth of about 3.75% and adjusted EPS of $3.16-$3.18, reflecting a challenging year including a cybersecurity incident.

Sentimentneutral 50

Neutral · 50 of 100

Impact80

high · market-wide

Confidence95%

high confidence · 11 wires

Eventdeveloping

v11 · alerted to followers

WHAT WE KNOW

Q3 2026 net sales: $5.138B, up 1.5% reported/operational/organic.